Edesa Biotech (EDSA) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $2.57, -3.75% vs the prior close of $2.67.
- Volume 64.03K shares, 1.0x its 50-day average.
- New SEC filings: 8-K (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
EDSA slides 3.7% to $2.57, a 6-month low. Closed at $2.57, -3.75% vs the prior close of $2.67. Day range $2.52–$2.77, opened at $2.68.
EDSA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — EDSA slides 3.7% to $2.57, a 6-month low
- Closed at $2.57, -3.75% vs the prior close of $2.67. Day range $2.52–$2.77, opened at $2.68.
- Volume was 64.03K shares, 1.0x its 50-day average of 62.01K.
- Price is -40.5% vs its 50-day average ($4.32) and -54.1% vs its 200-day average ($5.60).
- 52-week range $0.72–$20.32; today's close sits at 9% of that range, 87.4% below the 52-week high.
Oct 15, 2026 — EDSA rises 0.8% to $2.67
- Closed at $2.67, +0.75% vs the prior close of $2.65. Day range $2.54–$2.79, opened at $2.62.
- Volume was 75.80K shares, 1.2x its 50-day average of 61.12K.
- Price is -38.8% vs its 50-day average ($4.37) and -52.2% vs its 200-day average ($5.59).
- 52-week range $0.72–$20.32; today's close sits at 10% of that range, 86.9% below the 52-week high.
- SEC filings that day: 8-K.
Oct 14, 2026 — EDSA slides 7.0% to $2.65, a 6-month low, 5 down days in a row
- Closed at $2.65, -7.02% vs the prior close of $2.85. Day range $2.62–$2.84, opened at $2.84.
- Volume was 72.60K shares, 1.2x its 50-day average of 60.40K.
- Price is -40.0% vs its 50-day average ($4.42) and -52.6% vs its 200-day average ($5.59).
- 52-week range $0.72–$20.32; today's close sits at 10% of that range, 87.0% below the 52-week high.
- That makes 5 straight losses.
Oct 13, 2026 — EDSA slides 3.1% to $2.85, a 6-month low, 4 down days in a row
- Closed at $2.85, -3.06% vs the prior close of $2.94. Day range $2.82–$3.09, opened at $2.89.
- Volume was 59.70K shares, 1.0x its 50-day average of 59.98K.
- Price is -36.2% vs its 50-day average ($4.47) and -48.9% vs its 200-day average ($5.58).
- 52-week range $0.72–$20.32; today's close sits at 11% of that range, 86.0% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 — EDSA slides 16.2% to $2.94, a 6-month low, 3 down days in a row
- Closed at $2.94, -16.24% vs the prior close of $3.51. Day range $2.87–$3.56, opened at $3.56.
- Volume was 81.60K shares, 1.4x its 50-day average of 59.52K.
- Price is -34.9% vs its 50-day average ($4.52) and -47.2% vs its 200-day average ($5.57).
- 52-week range $0.72–$20.32; today's close sits at 11% of that range, 85.5% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — EDSA slides 4.1% to $3.51, a 6-month low
- Closed at $3.51, -4.10% vs the prior close of $3.66. Day range $3.49–$3.76, opened at $3.61.
- Volume was 36.50K shares, 0.6x its 50-day average of 60.32K.
- Price is -23.0% vs its 50-day average ($4.56) and -36.9% vs its 200-day average ($5.56).
- 52-week range $0.72–$20.32; today's close sits at 14% of that range, 82.7% below the 52-week high.
Oct 8, 2026 — EDSA slides 6.2% to $3.66
- Closed at $3.66, -6.15% vs the prior close of $3.90. Day range $3.66–$3.96, opened at $3.96.
- Volume was 51.40K shares, 0.8x its 50-day average of 61.95K.
- Price is -20.4% vs its 50-day average ($4.60) and -34.1% vs its 200-day average ($5.55).
- 52-week range $0.72–$20.32; today's close sits at 15% of that range, 82.0% below the 52-week high.
Oct 7, 2026 — EDSA jumps 4.8% to $3.90
- Closed at $3.90, +4.84% vs the prior close of $3.72. Day range $3.77–$4.01, opened at $3.77.
- Volume was 20.10K shares, 0.3x its 50-day average of 63.22K — lighter than usual.
- Price is -15.8% vs its 50-day average ($4.63) and -29.6% vs its 200-day average ($5.54).
- 52-week range $0.72–$20.32; today's close sits at 16% of that range, 80.8% below the 52-week high.
Oct 6, 2026 — EDSA slides 4.9% to $3.72
- Closed at $3.72, -4.86% vs the prior close of $3.91. Day range $3.72–$4.00, opened at $3.91.
- Volume was 12.80K shares, 0.2x its 50-day average of 64.75K — lighter than usual.
- Price is -20.0% vs its 50-day average ($4.65) and -32.7% vs its 200-day average ($5.53).
- 52-week range $0.72–$20.32; today's close sits at 15% of that range, 81.7% below the 52-week high.
Oct 5, 2026 — EDSA rises 1.3% to $3.91
- Closed at $3.91, +1.30% vs the prior close of $3.86. Day range $3.80–$4.22, opened at $3.80.
- Volume was 69.90K shares, 1.1x its 50-day average of 64.38K.
- Price is -16.5% vs its 50-day average ($4.68) and -29.2% vs its 200-day average ($5.52).
- 52-week range $0.72–$20.32; today's close sits at 16% of that range, 80.8% below the 52-week high.
Oct 2, 2026 — EDSA slides 3.7% to $3.86
- Closed at $3.86, -3.74% vs the prior close of $4.01. Day range $3.81–$4.01, opened at $4.01.
- Volume was 18.40K shares, 0.3x its 50-day average of 65.91K — lighter than usual.
- Price is -18.1% vs its 50-day average ($4.71) and -29.9% vs its 200-day average ($5.51).
- 52-week range $0.72–$20.32; today's close sits at 16% of that range, 81.0% below the 52-week high.
EDSA latest news & SEC filings
Every SEC filing by or about EDSA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Oct 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Nijhawan Pardeep received an award of 6,893 shares on Oct 5, 2026; now holds 905,993
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 26, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 25, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 25, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 20, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 8.01 — Reported other events the company considers important.
Aug 20, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 19, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$5.41M (prior year -$1.75M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.60 (prior year -$0.25) (loss widened vs Jun 30, 2025)
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 13, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Jul 13, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade EDSA
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Feb 13, 2026, Dec 12, 2025. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.82% (largest 18.3%). That is a volatile stock.
- Liquidity: about 44.05K shares (≈$113.20K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.57 vs a range of $0.72–$20.32 (9% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Pardeep Nijhawan bought 1,000 shares on Mar 10, 2026.
- Latest filings: 8-K Oct 15, 2026; 8-K Aug 20, 2026; 10-Q Aug 13, 2026.
- Share count: 9.64M shares outstanding (Aug 13, 2026), +37.0% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
EDSA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 2.68 | 2.77 | 2.52 | 2.57 | 64.03K |
| Oct 15, 2026 | 2.62 | 2.79 | 2.54 | 2.67 | 75.80K |
| Oct 14, 2026 | 2.84 | 2.84 | 2.62 | 2.65 | 72.60K |
| Oct 13, 2026 | 2.89 | 3.09 | 2.82 | 2.85 | 59.70K |
| Oct 12, 2026 | 3.56 | 3.56 | 2.87 | 2.94 | 81.60K |
| Oct 9, 2026 | 3.61 | 3.76 | 3.49 | 3.51 | 36.50K |
| Oct 8, 2026 | 3.96 | 3.96 | 3.66 | 3.66 | 51.40K |
| Oct 7, 2026 | 3.77 | 4.01 | 3.77 | 3.90 | 20.10K |
| Oct 6, 2026 | 3.91 | 4.00 | 3.72 | 3.72 | 12.80K |
| Oct 5, 2026 | 3.80 | 4.22 | 3.80 | 3.91 | 69.90K |
| Oct 2, 2026 | 4.01 | 4.01 | 3.81 | 3.86 | 18.40K |
| Oct 1, 2026 | 4.15 | 4.16 | 3.91 | 4.01 | 15.50K |
| Sep 30, 2026 | 3.57 | 4.27 | 3.51 | 4.21 | 84.60K |
| Sep 29, 2026 | 3.59 | 3.73 | 3.47 | 3.56 | 41.20K |
| Sep 28, 2026 | 4.04 | 4.04 | 3.64 | 3.65 | 48.20K |
| Sep 25, 2026 | 4.04 | 4.10 | 3.97 | 4.01 | 15.50K |
| Sep 24, 2026 | 3.90 | 4.15 | 3.90 | 4.03 | 19.60K |
| Sep 23, 2026 | 4.02 | 4.09 | 3.97 | 3.97 | 25.50K |
| Sep 22, 2026 | 4.02 | 4.20 | 4.02 | 4.07 | 26.00K |
| Sep 21, 2026 | 4.17 | 4.24 | 3.99 | 4.11 | 42.00K |
About Edesa Biotech
Edesa Biotech (EDSA) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in TORONTO. State of incorporation: British Columbia, Canada. Fiscal year ends September 30. SEC CIK 1540159.
EDSA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Joan Chypyha | Director | May 29, 2026 |
| Da David Liu | Director | May 29, 2026 |
| Sean Arthur Macdonald | Director | May 29, 2026 |
| Patrick Marshall | Director | May 29, 2026 |
| Pardeep Nijhawan | Chief Executive Officer | Sep 1, 2026 |
| Charles V Olson | Director | May 29, 2026 |
| Carlo Sistilli | Director | May 29, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Michael J Brooks | President | May 29, 2026 |
| Pardeep Nijhawan | Chief Executive Officer | Sep 1, 2026 |
| Peter J. Weiler | Chief Financial Officer | May 29, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Mar 10, 2026 | Pardeep Nijhawan | Buy | 1,000 | $6.60 |
| Mar 10, 2026 | Pardeep Nijhawan | Buy | 1,000 | $6.60 |
| Mar 10, 2026 | Pardeep Nijhawan | Buy | 1,000 | $6.60 |
| Mar 10, 2026 | Pardeep Nijhawan | Buy | 1,000 | $6.60 |
| Mar 5, 2026 | Pardeep Nijhawan | Buy | 10,000 | $3.90 |
| Mar 5, 2026 | Pardeep Nijhawan | Buy | 10,000 | $3.90 |
| Mar 5, 2026 | Pardeep Nijhawan | Buy | 10,000 | $3.90 |
| Mar 5, 2026 | Pardeep Nijhawan | Buy | 10,000 | $3.90 |
| Mar 4, 2026 | Pardeep Nijhawan | Buy | 10,000 | $4.26 |
| Mar 4, 2026 | Pardeep Nijhawan | Buy | 10,000 | $4.26 |
| Mar 4, 2026 | Pardeep Nijhawan | Buy | 10,000 | $4.26 |
| Mar 4, 2026 | Pardeep Nijhawan | Buy | 10,000 | $4.26 |
| Mar 3, 2026 | Pardeep Nijhawan | Buy | 10,000 | $3.63 |
| Mar 3, 2026 | Pardeep Nijhawan | Buy | 10,000 | $3.63 |
| Mar 3, 2026 | Pardeep Nijhawan | Buy | 10,000 | $3.63 |
EDSA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Sep 30, 2025 | — | $-7.19M | — | $-7.32M |
| Sep 30, 2024 | — | $-6.17M | — | $-4.89M |
| Sep 30, 2023 | — | $-8.37M | — | $-6.64M |
| Sep 30, 2022 | — | $-17.55M | — | $-12.28M |
| Sep 30, 2021 | $0 | $-13.34M | — | $-13.66M |
Latest balance sheet: total assets $12.72M, total liabilities $1.83M, cash $10.30M (as of Jun 30, 2026).
EDSA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $5.43 |
| May 14, 2026 | 8-K Item 2.02 (results) | $14.61 |
| Feb 13, 2026 | 8-K Item 2.02 (results) | $1.02 |
| Dec 12, 2025 | 8-K Item 2.02 (results) | $1.74 |
| Aug 8, 2025 | 8-K Item 2.02 (results) | $2.12 |
| May 14, 2025 | 8-K Item 2.02 (results) | $2.03 |
| Feb 14, 2025 | 8-K Item 2.02 (results) | $2.69 |
| Dec 13, 2024 | 8-K Item 2.02 (results) | $1.94 |
| Aug 9, 2024 | 8-K Item 2.02 (results) | — |
| May 10, 2024 | 8-K Item 2.02 (results) | — |
| Feb 9, 2024 | 8-K Item 2.02 (results) | — |
| Dec 15, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on EDSA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.